- Topic
28k Popularity
31k Popularity
142k Popularity
4k Popularity
18k Popularity
- Pin
- 🎉 Hey Gate Square friends! Non-stop perks and endless excitement—our hottest posting reward events are ongoing now! The more you post, the more you win. Don’t miss your exclusive goodies! 🚀
🆘 #Gate 2025 Semi-Year Community Gala# | Square Content Creator TOP 10
Only 1 day left! Your favorite creator is one vote away from TOP 10. Interact on Square to earn Votes—boost them and enter the prize draw. Prizes: iPhone 16 Pro Max, Golden Bull sculpture, Futures Vouchers!
Details 👉 https://www.gate.com/activities/community-vote
1️⃣ #Show My Alpha Points# | Share your Alpha points & gains
Post your - 🚀 ETH jumped to $4,600 this morning, up 8.69% in 24h!
Just shy of the $4,891 ATH—think it breaks through?
📍 Follow Gate_Square, vote and drop your reason.
🎁 4 winners split $100 Futures Voucher! - 💙 Gate Square #Gate Blue Challenge# 💙
Show your limitless creativity with Gate Blue!
📅 Event Period
August 11 – 20, 2025
🎯 How to Participate
1. Post your original creation (image / video / hand-drawn art / digital work, etc.) on Gate Square, incorporating Gate’s brand blue or the Gate logo.
2. Include the hashtag #Gate Blue Challenge# in your post title or content.
3. Add a short blessing or message for Gate in your content (e.g., “Wishing Gate Exchange continued success — may the blue shine forever!”).
4. Submissions must be original and comply with community guidelines. Plagiarism or re
Hanyu Pharmaceutical: The enrollment of all subjects in the Phase III clinical trial for the weight loss indication of Semaglutide Injection has been completed.
On June 12, Hanyu Pharmaceutical said on the interactive platform that the company's semaglutide injection was declared for marketing in accordance with Class 2.2, of which the bariatric indication had completed the enrollment of all subjects in the phase III clinical trial in January this year, and was currently in the follow-up stage, and the project had entered the dose maintenance period. After the completion of the Phase III clinical trial in the future, the Company will submit a marketing application after collating and improving the clinical trial data in accordance with relevant regulatory requirements.